Lin T, Meegaskumbura M
Animals (Basel). 2025; 15(5).
PMID: 40075907
PMC: 11898199.
DOI: 10.3390/ani15050624.
Mardi A, Ghovahi A, Abbasvandi F, Amani D
Biochem Genet. 2025; .
PMID: 40064800
DOI: 10.1007/s10528-025-11057-8.
Lin H, Jeon A, Chen K, Lee C, Wu L, Chong S
Br J Cancer. 2025; .
PMID: 40057667
DOI: 10.1038/s41416-025-02969-8.
Moiz S, Saha B, Mondal V, Bishnu D, Das B, Bose B
Noncoding RNA. 2025; 11(1).
PMID: 39997610
PMC: 11858122.
DOI: 10.3390/ncrna11010010.
Mohammed O
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 39976718
DOI: 10.1007/s00210-025-03898-2.
The evolution and application of RNA-focused small molecule libraries.
Taghavi A, Springer N, Zanon P, Li Y, Li C, Childs-Disney J
RSC Chem Biol. 2025; .
PMID: 39957993
PMC: 11824871.
DOI: 10.1039/d4cb00272e.
Selective arm-usage of pre-miR-1307 dysregulates angiogenesis and affects breast cancer aggressiveness.
Sumer O, Schelzig K, Jung J, Li X, Moros J, Schwarzmuller L
BMC Biol. 2025; 23(1):25.
PMID: 39849498
PMC: 11756181.
DOI: 10.1186/s12915-025-02133-x.
Perspectives in MicroRNA Therapeutics for Cystic Fibrosis.
Finotti A, Gambari R
Noncoding RNA. 2025; 11(1.
PMID: 39846681
PMC: 11755495.
DOI: 10.3390/ncrna11010003.
Identification and analysis of pancreatic intraepithelial neoplasia: opportunities and challenges.
Pian L, Song M, Wang T, Qi L, Peng T, Xie K
Front Endocrinol (Lausanne). 2025; 15():1401829.
PMID: 39839479
PMC: 11746065.
DOI: 10.3389/fendo.2024.1401829.
Advancements in gene therapies targeting mutant KRAS in cancers.
Wang Y, Bui T, Yang X, Hutvagner G, Deng W
Cancer Metastasis Rev. 2025; 44(1):24.
PMID: 39820726
PMC: 11748474.
DOI: 10.1007/s10555-025-10243-9.
Significance of Biogenetic Markers in Giant Cell Tumor Differentiation and Prognosis: A Narrative Review.
Taqi M, Ul Rasool H, Zaka Haider M, Al Muderis M
Diagnostics (Basel). 2025; 15(1.
PMID: 39795567
PMC: 11719472.
DOI: 10.3390/diagnostics15010039.
The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma.
Koumpis E, Georgoulis V, Papathanasiou K, Papoudou-Bai A, Kanavaros P, Kolettas E
Biomedicines. 2025; 12(12.
PMID: 39767565
PMC: 11673977.
DOI: 10.3390/biomedicines12122658.
rs11614913 C Allele is Associated with Increased Wilms Tumor Susceptibility in Chinese Children.
Luo M, Wang Y, Yin H, Zhou C, Lu H, Zhou H
J Cancer. 2025; 16(2):479-485.
PMID: 39744493
PMC: 11685685.
DOI: 10.7150/jca.102801.
Unlocking the epigenetic code: new insights into triple-negative breast cancer.
Mahendran G, Shangaradas A, Romero-Moreno R, Wickramarachchige Dona N, Sarasija S, Perera S
Front Oncol. 2025; 14:1499950.
PMID: 39744000
PMC: 11688480.
DOI: 10.3389/fonc.2024.1499950.
Metformin's effect on metabolic dysfunction-associated steatotic liver disease through the miR-200a-5p and AMPK/SERCA2b pathway.
Chen H, Huang M, Zhang D, Wang H, Wang D, Li M
Front Pharmacol. 2025; 15:1477212.
PMID: 39741625
PMC: 11685231.
DOI: 10.3389/fphar.2024.1477212.
Atorvastatin inhibits glioma glycolysis and immune escape by modulating the miR-125a-5p/TXLNA axis.
Gao K, Zhou T, Yin Y, Sun X, Jiang H, Li T
Hereditas. 2024; 161(1):54.
PMID: 39726023
PMC: 11670371.
DOI: 10.1186/s41065-024-00349-5.
Out-of-Equilibrium ceRNA Crosstalk.
Ferro E, Szischik C, Cunial M, Ventura A, De Martino A, Bosia C
Methods Mol Biol. 2024; 2883:167-193.
PMID: 39702709
DOI: 10.1007/978-1-0716-4290-0_8.
HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives.
Nazari M, Babakhanzadeh E, Mollazadeh A, Ahmadzade M, Mohammadi Soleimani E, Hajimaqsoudi E
Cancer Cell Int. 2024; 24(1):415.
PMID: 39702144
PMC: 11660992.
DOI: 10.1186/s12935-024-03612-x.
AEmiGAP: AutoEncoder-Based miRNA-Gene Association Prediction Using Deep Learning Method.
Yoon S, Yoon H, Cho J, Lee K
Int J Mol Sci. 2024; 25(23).
PMID: 39684787
PMC: 11641653.
DOI: 10.3390/ijms252313075.
Knowledge graph and frontier trends in melanoma-associated ncRNAs: a bibliometric analysis from 2006 to 2023.
Wang R, Zhu X, Wang Y
Front Oncol. 2024; 14:1439324.
PMID: 39659781
PMC: 11628868.
DOI: 10.3389/fonc.2024.1439324.